Insights

Perspective, tips, and resources for moving health forward

All Insights Health Systems Pharmacies Physician Practices Manufacturers Animal Health

AmerisourceBergen

Biosimilars pipeline report: A guide for understanding the growing market

AmerisourceBergen

June 2024

Manufacturers

A Biosimilars Roadmap: Understanding Payer Perceptions

AmerisourceBergen

May 2024

Manufacturers

Webinar: Bracing for the Impact of Biosimilars: Navigating Terrain in the U.S. Market Landscape

FormularyDecisions

May 2024

Physician Practices

Biosimilars pipeline report: A guide for understanding the growing market

AmerisourceBergen

April 2024

Manufacturers

Cencora's Brian Biehn and Corey Ford recommend adaptations for biosimilar regulatory frameworks

AmerisourceBergen

January 2024

Manufacturers

Podcast: How 2023 will shape the US Biosimilar space for 2024 and beyond

AmerisourceBergen

January 2024

Manufacturers

Cencora's Brian Biehn Forecasts Big Changes for the US Biosimilar Space

AmerisourceBergen

December 2023

Manufacturers

Untangle the complexities of launching a biosimilar

AmerisourceBergen

October 2023

Manufacturers

Recap Asembia 2023: Our impactful contributions to the premier specialty pharmacy conference

AmerisourceBergen

May 2023

Manufacturers

Education: The centerpiece of biosimilar adoption

AmerisourceBergen

February 2023

Manufacturers

Podcast: Conversations around interchangeability and biosimilar entries in new therapeutic categories

AmerisourceBergen

September 2022

Manufacturers

Podcast: Milestones for biosimilars in 2022 and looking ahead to 2023

AmerisourceBergen

July 2022

Manufacturers

Manufacturers

Webinar: uptake or heartbreak with biosimilars? Progress and perspectives

AmerisourceBergen

February 2021

Health Systems

Biosimilars: Patents, policy, and reimbursement

Sean McGowan; Steve Miller; David Senior

AmerisourceBergen

October 2020

Manufacturers

Physician Q&A: How to Boost Confidence in Biosimilars

Kashyap Patel, MD

Carolina Blood and Cancer Care

February 2020

Manufacturers

Video: Removing Barriers for Biosimilars

AmerisourceBergen

February 2020

Manufacturers

Biosimilars Check Up: Part 2

AmerisourceBergen

December 2019

We asked 100 physicians to share their perspectives on biosimilar utilization, cost savings, and adoption barriers. See what they said and what it means for the market and manufacturers.

Manufacturers

Infographic: Physician Perspectives on Biosimilars

AmerisourceBergen

December 2019

Manufacturers

Biosimilars: Market Insights and Growth Factors

Sean McGowan; Rick Lozano

AmerisourceBergen

September 2019

The growth of biosimilars presents a significant opportunity to reduce the cost of care and provide patients with greater access to affordable treatments. Our experts assess the current state and future of the biosimilars market.

Manufacturers

Biosimilars: Launch Insights From the Field

Xcenda

September 2019

How are biosimilar manufacturers approaching patients, providers and payers? What can they do to differentiate? Xcenda shares insight from our field programs.

Manufacturers

Biosimilars: Shaping a Moving Market

AmerisourceBergen

September 2019

An animated, immersive biosimilar market snapshot with actionable insight for manufacturers.

Manufacturers

Biosimilars Check Up: Physician Survey Results

AmerisourceBergen

September 2019

We asked 100 physicians to share their perspectives on biosimilar utilization, cost savings, and adoption barriers. See what they said and what it means for the market and manufacturers.

Manufacturers

The Growth of Biosimilars in the Oncology Pipeline

Dave Picard

AmerisourceBergen

September 2017

What should biosimilar manufacturers focus on for commercialization success?

Manufacturers

Improving Customer Experience and Driving Long-Term Value for Manufacturers

Rich Tremonte

AmerisourceBergen

August 2017

Rich Tremonte on the current healthcare landscape, the role of the wholesaler and how the new organizational structure at AmerisourceBergen brings out the best in both.

Insights

Biosimilars pipeline report: A guide for understanding the growing market

A Biosimilars Roadmap: Understanding Payer Perceptions

Webinar: Bracing for the Impact of Biosimilars: Navigating Terrain in the U.S. Market Landscape

Biosimilars pipeline report: A guide for understanding the growing market

Cencora's Brian Biehn and Corey Ford recommend adaptations for biosimilar regulatory frameworks

Podcast: How 2023 will shape the US Biosimilar space for 2024 and beyond

Cencora's Brian Biehn Forecasts Big Changes for the US Biosimilar Space

Untangle the complexities of launching a biosimilar

Recap Asembia 2023: Our impactful contributions to the premier specialty pharmacy conference

Education: The centerpiece of biosimilar adoption

Podcast: Conversations around interchangeability and biosimilar entries in new therapeutic categories

Podcast: Milestones for biosimilars in 2022 and looking ahead to 2023

Why biopharma companies must understand barriers to biosimilar adoption

Podcast: Insulin biosimilars part 2

Podcast: Insulin biosimilars part 1

Webinar: uptake or heartbreak with biosimilars? Progress and perspectives

Biosimilars: Patents, policy, and reimbursement

Physician Q&A: How to Boost Confidence in Biosimilars

Video: Removing Barriers for Biosimilars

Biosimilars Check Up: Part 2

Infographic: Physician Perspectives on Biosimilars

Biosimilars: Market Insights and Growth Factors

Biosimilars: Launch Insights From the Field

Biosimilars: Shaping a Moving Market

Biosimilars Check Up: Physician Survey Results

The Growth of Biosimilars in the Oncology Pipeline

Improving Customer Experience and Driving Long-Term Value for Manufacturers